- Veterinary medicines supplier Animalcare's total divided of 4.5p per share is 12.5% up on last time - despite a fall in revenues and profits.

Underlying profits before tax from continuing operations fell by 21.7% to £2.3m in the year to the end of June while revenues were down 8.2% at £10.9m although sales of licensed veterinary medicines (excluding Buprecare ampoules) rose 16.8%.

Chairman James Lambert said: "As anticipated, this has been a difficult year for Animalcare but I believe the measures the board has taken during it will see the business beginning to grow again during the current financial year.

"The board believes with the focus on growing our Companion Animal Identification business, the resumption of supply of Buprecare ampoules, and the planned launch of four new licensed veterinary products during the financial year Animalcare should return to growth."

And he said the board is encouraged by current trading for the beginning of the new financial year."

At 8:12am: [LON:ANCR] share price was 0p at 138p

Story provided by